Related Experiment Videos
Improving regulatory capacity to manage risks associated with trade agreements
Helen L Walls1,2,3, Richard D Smith4,5, Peter Drahos6,7
1London School of Hygiene and Tropical Medicine, London, UK. helen.walls@lshtm.ac.uk.
Globalization and Health
|April 19, 2015
Summary
Preferential trade agreements (PTAs) pose public health risks, requiring strong government capacity for negotiation and management. Insufficient administrative capacity, especially in developing nations, can worsen health inequities.
Area of Science:
- Public Health
- International Trade Law
- Health Policy
Background:
- Modern trade negotiations result in numerous preferential trade agreements (PTAs).
- These PTAs present significant risks to public health.
- Governments face increasing demands to enhance administrative and regulatory capacities for PTA management.
Purpose of the Study:
- To highlight the importance of administrative regulatory capacity and coordination in managing public health risks associated with PTAs.
- To suggest strategies for countries to improve their capacity in this area.
Main Methods:
- The study analyzes the administrative and regulatory capacity required at different stages of PTAs (negotiation, implementation, management).
- It examines the resource-intensive nature of building and maintaining this capacity.
- The focus is on the challenges faced by smaller and poorer states, particularly developing countries.
Main Results:
- Administrative regulatory capacity needs differ across PTA negotiation, implementation, and management phases.
- Building and maintaining this capacity is expensive, skill-intensive, and requires substantial infrastructure.
- Smaller, poorer states, and developing countries disproportionately struggle to acquire the necessary capacity.
Conclusions:
- PTAs can exacerbate health inequities if states lack adequate administrative regulatory capacity.
- Strengthening capacity is crucial for mitigating public health risks and ensuring equitable outcomes from trade agreements.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
679
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
679
Global Regulatory Systems
927
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
927
Drug Regulation
3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
384
Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
384
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
85
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
85
Improving Translational Accuracy
3.8K
3.8K